Organic potassium salts
Medchemexpress LLC GJ071 oxalate | 1216676-34-4 | 99.7% | 455.53 g/mol | C20H29N3O7S | 5 MG
GJ071 oxalate is a research-grade small molecule reported to induce ATM kinase activity in ataxia telangiectasia (A-T) cells carrying homozygous TGA or TAG stop codons. Supplied as the oxalate salt for laboratory research use.
- Induces ATM kinase activity in A-T cells with TGA or TAG stop codons.
- High purity: 99.74%.
- Molecular formula: C20H29N3O7S; molecular weight: 455.53 g/mol.
- Available in small-scale laboratory quantities (1 mg-100 mg).
- Suitable for cellular research applications; soluble in DMSO.
Chemscene ChemScene | Potassium (4-cyanophenyl)trifluoroborate | 5G | CS-W015180 | 0.98 | 850623-36-8| MFCD04115736 | 209.02
ChemScene | Potassium (4-cyanophenyl)trifluoroborate | 5G | CS-W015180 | 0.98 | 850623-36-8| MFCD04115736 | 209.02
Chemscene ChemScene | Potassium trifluoro(2-methoxyphenyl)borate | 5G | CS-W014951 | 0.97 | 236388-46-8| MFCD04115756 | 214.036
ChemScene | Potassium trifluoro(2-methoxyphenyl)borate | 5G | CS-W014951 | 0.97 | 236388-46-8| MFCD04115756 | 214.036
Selleck Chemical LLC Nafronyl oxalate salt S5472-25mg
Nafronyl oxalate salt is the oxalate salt form of nafronyl which is a selective antagonist of 5-HT2 receptors and a vasodilator used in the management of peripheral and cerebral vascular disorders
Cayman Chemical Xanomeline oxalate
A potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively); has antipsychotic-like activities in rats and Cebus monkeys; enhances memory function and has utility in treating Alzheimer’s Disease
Medchemexpress LLC N,N'-dinitrosopiperazine | 140-79-4 | MFCD00014615 | >95.0% | 144.13 | C4H8N4O2 | 5 MG
N,N'-dinitrosopiperazine is a small-molecule nitrosamine reagent used in biochemical and toxicological research. It is reported as a carcinogen with specificity for the nasopharyngeal epithelium and is supplied as a solid research chemical to be handled with appropriate laboratory safety precautions.
- Small-molecule nitrosamine used for biochemical and toxicological research.
- Documented carcinogenic activity with nasopharyngeal specificity in the literature.
- Provided as a high-purity reagent suitable for analytical applications.
- Available in small vial sizes appropriate for assay-scale use.
- Store at 4°C and protect from light; in solution, store at -80°C for long-term stability.
Cayman Chemical Xanomeline oxalate
A potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively); has antipsychotic-like activities in rats and Cebus monkeys; enhances memory function and has utility in treating Alzheimer’s Disease
![eMolecules 140-92-1 | ISOPROPYLXANTHIC ACID POTASSIUM SALT | AstaTech174.320 | C4H7KOS2 | 95.000 | [K+].CC(C)OC([S-])=S | 1g | 718064034](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502442125.PNG-250.jpg)
eMolecules 140-92-1 | ISOPROPYLXANTHIC ACID POTASSIUM SALT | AstaTech174.320 | C4H7KOS2 | 95.000 | [K+].CC(C)OC([S-])=S | 1g | 718064034
ISOPROPYLXANTHIC ACID POTASSIUM SALT | AstaTech | 140-92-1174.320 | C4H7KOS2 | 95.000 | [K+].CC(C)OC([S-])=S | 1g | 718064034
Medchemexpress LLC Naloxegol oxalate | 1354744-91-4 | 99.9% | C36H55NO15 | 1 ML
Naloxegol oxalate | 1354744-91-4 | 99.9% | C36H55NO15 | 1 ML
eMolecules 95-92-1 | Ethyl oxalate | Chem-Impex | MFCD00009119 | 146.142 | C6H10O4 | 99.000 | CCOC(=O)C(=O)OCC | 250g | 112767526
Ethyl oxalate | Chem-Impex | 95-92-1 | MFCD00009119 | 146.142 | C6H10O4 | 99.000 | CCOC(=O)C(=O)OCC | 250g | 112767526
Sigma Aldrich Fine Chemicals Biosciences Phospho(enol)pyruvic acid monopotassium salt | 4265-07-0 | MFCD00044476 | 1g
Phospho(enol)pyruvic acid monopotassium salt | Purity: ≥97% | Mol Wt: 206.13 | 4265-07-0 | MFCD00044476 | 1g
Medchemexpress LLC Naloxegol oxalate | 1354744-91-4 | 99.91% | C36H55NO15 | 100 MG
Naloxegol oxalate is an orally active, peripherally acting μ-opioid receptor antagonist. It inhibits the binding of opioids to μ-opioid receptors in the gastrointestinal tract, alleviating opioid-induced gastrointestinal hypomotility, delayed transit, hypertonicity, and increased fluid reabsorption. It is used in research related to opioid-induced constipation.
- Binds with high affinity to μ-opioid and κ-opioid receptors
- Exhibits low affinity to δ-opioid receptors in vitro
- Shows no significant activity at non-opioid targets
- Alleviates opioid-induced slowed gastrointestinal motility and transit